Artroniq Berhad Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Artroniq Berhad has been growing earnings at an average annual rate of 8.6%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 8.4% per year.
Belangrijke informatie
8.6%
Groei van de winst
30.4%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 8.9% |
| Inkomstengroei | 8.4% |
| Rendement op eigen vermogen | -4.9% |
| Nettomarge | -11.4% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
More Unpleasant Surprises Could Be In Store For Artroniq Berhad's (KLSE:ARTRONIQ) Shares After Tumbling 42%
Jan 17
Artroniq Berhad's (KLSE:ARTRONIQ) Shares Not Telling The Full Story
Jul 06Returns At Artroniq Berhad (KLSE:ARTRONIQ) Are On The Way Up
Nov 12Slowing Rates Of Return At Artroniq Berhad (KLSE:ARTRONIQ) Leave Little Room For Excitement
Jun 08We Think Artroniq Berhad (KLSE:ARTRONIQ) Needs To Drive Business Growth Carefully
Jan 19We're Keeping An Eye On Artroniq Berhad's (KLSE:ARTRONIQ) Cash Burn Rate
Oct 06Companies Like Artroniq Berhad (KLSE:ARTRONIQ) Can Afford To Invest In Growth
Apr 16The Artroniq Berhad (KLSE:ARTRONIQ) Share Price Has Soared 472%, Delighting Many Shareholders
Feb 04Opbrengsten en kosten
Hoe Artroniq Berhad geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 38 | -4 | 13 | 0 |
| 30 Jun 23 | 99 | -8 | 19 | 0 |
| 31 Dec 22 | 143 | 2 | 10 | 0 |
| 30 Sep 22 | 202 | 0 | 10 | 0 |
| 30 Jun 22 | 261 | 0 | 8 | 0 |
| 31 Mar 22 | 289 | 0 | 7 | 0 |
| 31 Dec 21 | 269 | 0 | 7 | 0 |
| 30 Sep 21 | 247 | -1 | 6 | 0 |
| 30 Jun 21 | 219 | -4 | 7 | 0 |
| 31 Mar 21 | 188 | -4 | 6 | 0 |
| 31 Dec 20 | 168 | -4 | 5 | 0 |
| 30 Sep 20 | 133 | -3 | 4 | 0 |
| 30 Jun 20 | 110 | -1 | 3 | 0 |
| 31 Mar 20 | 85 | 0 | 2 | 0 |
| 31 Dec 19 | 97 | 0 | 2 | 0 |
| 30 Sep 19 | 81 | -6 | 4 | 0 |
| 30 Jun 19 | 56 | -7 | 5 | 0 |
| 31 Mar 19 | 64 | -5 | 5 | 0 |
| 31 Dec 18 | 47 | -5 | 5 | 0 |
| 30 Sep 18 | 53 | -1 | 4 | 0 |
| 30 Jun 18 | 55 | -1 | 4 | 0 |
| 31 Mar 18 | 51 | -4 | 4 | 0 |
| 31 Dec 17 | 47 | -3 | 4 | 0 |
| 30 Sep 17 | 48 | -1 | 3 | 0 |
| 30 Jun 17 | 49 | 0 | 3 | 0 |
| 31 Mar 17 | 54 | 1 | 3 | 0 |
| 31 Dec 16 | 58 | 1 | 3 | 0 |
| 30 Sep 16 | 61 | 1 | 3 | 0 |
| 30 Jun 16 | 62 | 2 | 3 | 0 |
| 31 Mar 16 | 57 | 2 | 3 | 0 |
| 31 Dec 15 | 56 | 2 | 3 | 0 |
| 30 Sep 15 | 51 | 1 | 5 | 0 |
| 30 Jun 15 | 48 | 0 | 4 | 0 |
| 31 Mar 15 | 50 | 0 | 4 | 0 |
| 31 Dec 14 | 52 | 0 | 3 | 0 |
| 30 Sep 14 | 53 | -1 | 3 | 0 |
| 30 Jun 14 | 55 | 0 | 3 | 0 |
| 31 Mar 14 | 62 | 1 | 3 | 0 |
| 31 Dec 13 | 63 | 1 | 3 | 0 |
Kwaliteitswinsten: ARTRONIQ is currently unprofitable.
Groeiende winstmarge: ARTRONIQ is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ARTRONIQ is unprofitable, but has reduced losses over the past 5 years at a rate of 8.6% per year.
Versnelling van de groei: Unable to compare ARTRONIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ARTRONIQ is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (24.4%).
Rendement op eigen vermogen
Hoge ROE: ARTRONIQ has a negative Return on Equity (-4.89%), as it is currently unprofitable.